Inhibitor development in patients with type 3 Von Willebrand disease, a comprehensive study on 99 Iranian patients
- 6 February 2021
- journal article
- letter
- Published by Wiley in Haemophilia
- Vol. 27 (4), 0520-E524
- https://doi.org/10.1111/hae.14266
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- von Willebrand DiseasePublished by Springer Science and Business Media LLC ,2018
- Intracranial hemorrhage in congenital bleeding disordersBlood Coagulation & Fibrinolysis, 2018
- von Willebrand Disease: Differential Diagnosis and Diagnostic Approach to Specific SubtypesPublished by Springer Science and Business Media LLC ,2016
- Type 3 VWD and an inhibitor to VWF: Challenges in diagnosisThe Journal of Haemophilia Practice, 2016
- Nijmegen-Bethesda Assay to Measure Factor VIII InhibitorsMethods in molecular biology (Clifton, N.J.), 2013
- Antibodies to von Willebrand factor in von Willebrand diseaseAdvances in Experimental Medicine and Biology, 1995
- Alloantibodies in congenital von Willebrand’s diseaseLa Ricerca in Clinica e in Laboratorio, 1991